跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,735 条关于
“scalp psoriasis”
全部
4,735
临床试验
3,861
药物
74
机构
7
资讯
793
去年
Deucravacitinib Demonstrates Efficacy for Scalp and Overall Psoriasis in Phase 3 and Real-World Studies
去年
FDA Accepts Roflumilast Foam sNDA for Scalp and Body Psoriasis Treatment
去年
Bristol Myers Squibb Announces Positive Data for Sotyktu in Moderate to Severe Psoriasis
去年
Fall Clinical 2024 Highlights Advances in Acne, Psoriasis, Atopic Dermatitis, and Aesthetic Dermatology
去年
Guselkumab Demonstrates High Efficacy for Psoriasis Treatment Across All Skin Tones in Landmark VISIBLE Trial
2年前
New Research Reveals Significant Disparities in Psoriasis Impact Across Racial and Ethnic Groups
去年
Roflumilast Foam Shows Promise in Reducing Itch and Improving Quality of Life for Psoriasis Patients
去年
VISIBLE Study Shows Guselkumab Effective for Psoriasis in Skin of Color Patients
去年
FDA Anticipated to Decide on Dupixent, Pz-cel, and Roflumilast Foam for Dermatologic Conditions by Mid-2025
去年
VISIBLE Trial Demonstrates Strategies for Enhancing Diversity in Psoriasis Research
第 1 页,共 80 页
上一页
下一页